SAT-140 A Drug-Drug Interaction Trial of Oral Semaglutide with Levothyroxine and Multiple Coadministered Tablets

Introduction: Oral semaglutide contains the GLP-1 analog semaglutide co-formulated with the absorption enhancer, sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC). Aims: This trial investigated (A) the effect of oral semaglutide and SNAC alone on the pharmacokinetics (PK) of levothyroxine (thyr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hauge, Camilla, Breitschaft, Astrid, Hartoft-Nielsen, Marie-Louise, Jensen, Simon, Bækdal, Tine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Diabetes Mellitus and Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552044/
http://dx.doi.org/10.1210/js.2019-SAT-140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552044/
http://dx.doi.org/10.1210/js.2019-SAT-140

Ejemplares similares